Marco Bellone

3PUBLICATIONS
3CO-AUTHORS
Major global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 18, 2026
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy.

|Apr 21, 2025
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy.

Stefano Luminari, Antonio Pinto, Benedetta Puccini

|Dec 11, 2024
A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy.

Marco Bellone, Alice Sabinot, Alessandro D'Arpino

Pageof 1

Frequent Collaborators

2 joint publications

Alice Sabinot

2 joint publications

Emanuela Omodeo Salè

2 joint publications

Lorenzo Pradelli